Next Article in Journal
Host- and Microbiota-Derived Extracellular Vesicles, Immune Function, and Disease Development
Next Article in Special Issue
Dietary Control of Ganglioside Expression in Mammalian Tissues
Previous Article in Journal
Screening and Identification of Novel cGAS Homologues Using a Combination of in Vitro and In Vivo Protein Synthesis
Previous Article in Special Issue
Self-Assembly in Ganglioside‒Phospholipid Systems: The Co-Existence of Vesicles, Micelles, and Discs
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Effects of Gangliosides on Spermatozoa, Oocytes, and Preimplantation Embryos

1
CHA Fertility Center, 5455 Wilshire Blvd. Los Angeles, CA 90036, USA
2
Department of Biological Science, College of Natural Sciences, Wonkwang University, 460, Iksan-daero, Iksan-si, Jeollabuk-do 54538, Korea
3
Primate Resources Center (PRC), Korea Research Institute of Bioscience and Biotechnology, Neongme-gil, Ibam-myeon, Jeongup-si, Jeonvuk 56216, Korea
4
National Primate Research Center, Korea Research Institute of Bioscience and Biotechnology, 30, Yeonggudanji-ro, Ochang-eup, Cheongwon-gu, Cheongju-si, Chungcheongbuk-do 28116, Korea
5
Department of Physiology and Cell Biology, University of Nevada, Reno School of Medicine, Reno, NV 89557, USA
6
Institute for Glycoscience, Wonkwang University, 460, Iksan-daero, Iksan-si, Jeollabuk-do 54538, Korea
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2020, 21(1), 106; https://doi.org/10.3390/ijms21010106
Submission received: 23 October 2019 / Revised: 20 December 2019 / Accepted: 20 December 2019 / Published: 22 December 2019
(This article belongs to the Special Issue Gangliosides: Modes of Action and Cell Fates)

Abstract

:
Gangliosides are sialic acid-containing glycosphingolipids, which are the most abundant family of glycolipids in eukaryotes. Gangliosides have been suggested to be important lipid molecules required for the control of cellular procedures, such as cell differentiation, proliferation, and signaling. GD1a is expressed in interstitial cells during ovarian maturation in mice and exogenous GD1a is important to oocyte maturation, monospermic fertilization, and embryonic development. In this context, GM1 is known to influence signaling pathways in cells and is important in sperm–oocyte interactions and sperm maturation processes, such as capacitation. GM3 is expressed in the vertebrate oocyte cytoplasm, and exogenously added GM3 induces apoptosis and DNA injury during in vitro oocyte maturation and embryogenesis. As a consequence of this, ganglioside GT1b and GM1 decrease DNA fragmentation and act as H2O2 inhibitors on germ cells and preimplantation embryos. This review describes the functional roles of gangliosides in spermatozoa, oocytes, and early embryonic development.

1. Introduction

According to membrane theory, the plasma membrane is a mosaic bilayer in which dynamic changes in biological activity are mediated by proteins, lipid rafts, cholesterol, and sphingolipids [1,2,3]. Lipid rafts are sphingolipid and cholesterol-enriched plasma membrane microdomains that serve as platforms for protein segregation in the membrane [4]. Effective changes in the functional biology and molecular organization of the plasma membrane are induced by lipid raft aggregation, disaggregation, and differential partitioning kinetics between lipid-ordered and lipid-disordered regions of the plasma membrane [5]. These changes are important to establish polarity and asymmetry in membrane activities [6,7].
Gangliosides are sialic acid-containing acidic glycosphingolipids. Gangliosides are found in animal plasma membranes and are especially abundant in nervous cell membranes [8]. Many types of gangliosides have been separated from the brain in different species, and GM1, GD1a, GD1b, and GT1b comprise the large majority of gangliosides in the brains of all mammal species investigated [9]. Gangliosides are implicated in the control of cellular functions, serving as antigens, and play roles in cellular adhesion and signal transduction [10]. Several gangliosides have been demonstrated to regulate cell differentiation, cell growth, and play significant roles in the immune defense system. Overexpression of gangliosides in patients with renal cell carcinomas has been related to multiple T cell dysfunctions [11]. Elevated levels of GD3 found in ovarian cancer ascites fluid inhibit NKT cell activation [12] and apoptosis of T cells [13].
Reactive oxygen species (ROS) generation has been detected in reproductive and non-reproductive cells and modulated cellular survival and death. Hydrogen peroxide (H2O2) increases apoptosis by interrupting the antioxidant defense system during oocyte maturation and embryonic development in vitro [14,15]. The ability of various gangliosides to diminish lipid peroxidation accumulation and free radical scavenging has been explained in isolated rat myocardiocytes [16] and brain cells [17,18,19,20,21]. Exogenous application of gangliosides has been shown to affect biological events and cell properties, including protection against the oxidative stress of the cell. For example, treatment with GM1 protects against oxidative stress-induced neuronal cell injury and traumatic injury-induced brain edema [22]. Supplementation of GT1b to culture medium also protects human spermatozoa from DNA damage induced by ROS [23].
Gangliosides have been shown to modulate growth factor receptor activity, such as epidermal growth factor receptor (EGFR), platelet-derived growth factor receptor (PDGFR), and fibroblast growth factor receptor (FGFR) [24,25]. EGFR activation via EGF or EGF-like factors is recognized to impact the resumption of oocyte meiosis and cumulus cell expansion in rodents [26,27], pigs [28,29], and humans [30]. Expression of exogenous GM3 in the brain inhibits cell proliferation and induces apoptosis [31,32]. GM3 (Figure 1A) binds to the extracellular EGFR domain and inhibits the tyrosine kinase activity of EGFR. Addition of GM3 to the culture medium inhibits EGFR activity in a human epidermoid carcinoma cell line [33] and reduces the invasive potential of bladder tumors in mice [34]. GM3 also inhibits the tyrosine kinase activity of the EGFR in hepatoma cells [35] and induces cumulus cell apoptosis during in vitro maturation (IVM) of porcine oocytes. [36]. However, the growth of Siat9 (encoding GM3 synthase) and Galgt1 (encoding GM2 synthase)-deficient knock out cancer cells is strongly impeded both in vivo and vitro [37]. GM3 has also been known as an inhibitor of insulin receptor signaling. GM3 has been detected within pancreatic tissue, and pancreatic damage is related to increased GM3 abundance in streptozotocin (STZ)-induced diabetic rats [38,39].
Fertilization failure occurs with normal sperm and meiotically mature oocytes after conventional insemination in vitro. This unexpected outcome significantly reduces the chance of successful pregnancy. GM1 is a lipid raft and is involved in a variety of cell surface activities such as intracellular interactions, signal transduction, protein binding, and virus docking. Fertilization failure relates to defects in lipid raft microdomains enriched in GM1 at the level of the human oolemma in vitro [40]. Improved mechanisms to correlate the metabolism and molecular interactions of gangliosides with their biological functions will provide new probabilities for considering cellular regulation and will allow the manipulation of gangliosides for therapeutic advantage. This review concentrates on the effects of gangliosides in germ cells and preimplantation embryos.

2. Gangliosides

Glycosphingolipids (GSLs) are expressed on vertebrate cell membranes [41]. The main structure of GSLs, glucosylceramide, is synthesized on the cytoplasmic surface of the Golgi by glucosyl-ceramide synthase (GCS) via the transfer of a glucose residue from UDP-glucose to ceramide [42,43]. GCS is a transmembrane protein with its C-terminal catalytic domain located in the cytoplasm [44]. After glucosylceramide is synthesized and translocated into the Golgi lumen, it is modified by a series of Golgi glycosyltransferases to construct higher-order GSL structures [45]. Ceramide is described as an apoptotic trigger in some environments [46,47] and the apoptosis of germ cells and embryos can be caused by glucosylceramide synthase insufficiency.
Gangliosides are sialic acid-containing glycosphingolipids and are cell type-specific. Sialic acids are a large group of nine carbon α-keto acids that play a diversity of biological functions in cells [48,49]. Depending on the number of sialic acid residues on the inner galactose, gangliosides belong either to the a-ganglio series, the b-ganglio series, or the c-series [50]. GM1, related to the a-series of neuronal gangliosides, was the first complex ganglioside for which accurate chemical structure was explained [51], whereas GT1b (Figure 1B) possess three sialic acid residues; two connected to the internal galactose and one on the terminal galactose [2]. GM1 deficiencies have been detected in Huntington`s disease and Parkinson`s disease, while GM1 distribution and expression are shown to be affected in central nervous system injury caused by trauma or disease [52]. GD1a (Figure 1C) is specifically produced by the adding of sialic acid to GM1a (Figure 1D) by the synthesizing enzyme ST3 β-galactoside α-2, 3-sialyltransferase 2 (ST3GAL2) [24]. Gangliosides engage in membrane microdomains, serve as ligands of lectins, and modulate the activity of membrane proteins, such as the insulin receptor, leptin receptor, and EGFR [53,54,55,56,57,58,59,60]. In addition, gangliosides are a universal element of cell membranes with pleiotropic roles controlling intercellular activities during embryonic development, including those involved in reproductive processes [21,60]. GSL synthesis is essential for the differentiation of certain tissue and early embryonic development and supports the concept that GSLs are involved in crucial cell interactions mediating these processes [21].

3. Protective Effect of Gangliosides in Germ Cells and Early Embryos

Excessive ROS generation can increase DNA injury in the cell, including sperm, oocytes, and embryos. Mono-, di-, and trisialogangliosides have been shown to decrease the lipid peroxidation process (LPO) induced in brain synaptosomes by the ferrous-ascorbate induced lipid peroxidation [18] and to scavenge free radicals generated during myocardial ischemic reperfusion [61]. Yamamoto et al. [21] demonstrated that ganglioside GT1b suppressed brain mitochondrial DNA damage. Exogenously added GD1b and GT1b reduced the level of superoxide anions produced by phorbol,12-myristate acetate (PMA)-stimulated human sperm [18]. Gavella et al. [62] reported that ganglioside micelles attached to the ejaculated sperm membrane to provide a diffusion barrier and delayed ROS production (Figure 2). Moreover, exogenous GT1b increases the oocyte nuclear maturation rate by reducing ROS during porcine IVM [62].
Cryopreservation can be valuable for assisted reproductive technologies (ART) to preserve fertility; however, cryopreservation significantly increases DNA damage in cells. Several reports have proposed that DNA fragmentation can be mainly assigned to cryopreservation-produced ROS [63,64,65]. We reported that ganglioside GT1b was expressed in surviving murine embryos during the development of both fresh and frozen embryos [66]. These results demonstrate that GT1b suppresses DNA damage and participates in embryo survival and growth. During cryopreservation, a major site of injury is the plasma membrane. Gangliosides are involved in multiple functions, and it is important to understand how their distribution is modulated in the plasma membrane.
Cryopreservation-produced injury to the spermatozoa membrane manifests as changes in the organization and lipid arrangement of the membrane, leading to changes in spermatozoa permeability [67]. One of the suggested processes of spermatozoa defiance to cryostorage-produced damage is its ability to shed hydrophilic lipids, therefore increasing the hydrophobic features of the membrane and increasing spermatozoa tolerance to cryopreservation [68]. Gavella et al. [23] showed that treatment of GM1 and GT1b defended human spermatozoa DNA integrity during the freezing–thawing procedures. GM1-pretreated cryopreserved embryonic ventral mesencephalon (VM) plus a daily treatment with GM1 to the culture medium improves the low survival and functional inefficacy of grafts derived from cryopreserved VM in rats [69].

4. Effects of Gangliosides on Spermatozoa.

Spermatozoa undergo three distinct phases of maturation; spermatogenesis, epididymal maturation, and capacitation. Spermatogenesis occurs in the male testis and is responsible for the production of spermatozoa. Spermatozoa are able to swim and fertilize an oocyte after maturing in the epididymis. The epididymis is a duct and is subdivided into the head region, corpus region, and the tail region. Seminiferous tubules are located in the testis and new spermatogonia begin their division in the seminiferous tubules. In rat seminiferous tubules, GM3 is expressed in pachytene spermatocytes and spermatids; however, GM3 is not detected in spermatogonia [71]. It is suggested that GM3 might play a key role in maturation of spermatozoa and obtain a fertility ability. β1,4-N-Acetylgalactosaminyltransferase (β1,4GalNAc-T) is an important enzyme in the biosynthesis of complex gangliosides, because all complex gangliosides are synthesized through GM2 or GD2. Mice with a disrupted β1,4GalNAc-T gene allele, and the knockout mouse line of the β1,4GalNAc-T gene lack all complex ganglio-series gangliosides [72]. Given the fact that several seminiferous tubules showed entire lack of the germ cell in the β1,4GalNAc-T gene KO male mice, the result suggested that gangliosides are essential in the transport of testosterone to the seminiferous tubules and bloodstream from the Leydig cells in vivo [73].
Sperm capacitation is the process that confers the acquisition of fertilization-competence in the female reproductive tract and correlated with changes in sperm intracellular ion concentrations, metabolism, the plasma membrane, and motility [74,75,76]. Cholesterol is the major sterol in animal spermatozoa and intercalates between glycolipids and phospholipids in the hydrophobic interior of the cell membrane and increases or decreases order, depending on the degree of saturation or unsaturation of the fatty acyl chains [77]. GM1 localizes to the sterol-rich plasma membrane overlying the acrosome of sperm. During capacitation, GM1 localizes to the sterol-poor postacrosomal plasma membrane and then moves to the sterol-rich plasma membrane in rat spermatozoa [78]. The distribution of GM1 on ejaculated boar spermatozoa changes in a sequential manner from overlying the sperm tail to the sperm head during methyl-β-cyclodextrin(MBCD)-mediated capacitation [79]. In live bovine and mouse sperm heads, GM1 also localizes to the sterol-rich plasma membrane overlying the acrosome (APM), and labeling GM1 using the pentameric cholera toxin subunit B (CTB) induces a dramatic redistribution of signal from the APM to the sterol-poor postacrosomal plasma membrane upon sperm death [80]. In this context, the Cap-ScoreTM Sperm Function Test (Cap-Score) is a laboratory-developed test that is designed to assess sperm capacitation in vitro [81]. This assay therefore analyzes the GM1 localization patterns to evaluate the fertilizing ability of human sperm. Changes of GM1 may play an important role in mediating sperm–oocyte interactions in mammalian spermatozoa.

5. Gangliosides on Oocytes and Preimplantation Embryos

Sex hormones such as follicle stimulation hormone (FSH) and luteinizing hormone (LH) stimulate the continuation of the first meiotic division of oocytes and oocyte maturation, including nuclear and cytoplasmic changes during the developing gametes. During the oestrous cycle, follicular development, ovulation, and luteinization are regulated by cell–cell interactions and hormones, implying the importance of surface membrane components including gangliosides. GM1 and GM3 are expressed in theca cells during rat follicular development [82]. Cumulus cells provide metabolic and nutritional support for the oocytes. Cumulus expansion is essential for ovulation and influences oocyte maturation. In the hypophysectomized rat ovary, it has been shown that GM3 is expressed in cumulus and granulosa cells of Graafian follicles after gonadotropin stimulation, and these expression patterns are quite similar to those of normal adult rats [83].
EGFR is one of the receptor tyrosine kinases, and activation of EGFR induces numerous signaling pathways related to cell proliferation and resistance to apoptosis [22]. In this context, the exogenous GM3 inhibits EGF-induced phosphorylation of the EGF receptor at the Try-1173 residue, but enhances the phosphorylation of the Try-1088 residue [35]. Under these circumstances, both Try-1173 and Try-1086 residues serve as a docking site for the SH2-domain containing signaling molecules and lead to activation of the downstream signaling pathways. Similarly, GM3 inhibits c-fos and c-jun expression, and thus consequently the inhibition of c-fos and c-jun by GM3 is consistent with the inhibition of MAP kinase activity by GM3 [84]. Additionally, Park et al. [36] showed that in porcine cumulus-oocyte complexes (COCs), exogenous GM3 inhibits meiotic maturation and restricts the expansion of cumulus cells during in vitro meiotic maturation through EGFR-mediated PI3K/AKT signaling pathways and initiates apoptosis (Figure 3). GM3 also works and shows increased apoptosis in human colon cancer [85] and murine bladder cancer [34]. Addition of GM3 inhibits insulin-stimulated phosphorylation of the insulin receptor in 3T3-L1 and autophosphorylation of soluble receptors. In other words, the GM3 synthase knockout mice enhance ligand-induced insulin receptor phosphorylation and sensitivity to glucose [86]. Ju et al. [87] demonstrated that ganglioside GM3 expression increased in apoptotic preimplantation embryos. In relation to this, GM3 is involved in transmembrane signaling modulation of growth factor receptor activities, and in cell adhesion and motility, whereby GM3 expression is decreased during ovarian maturation and early embryonic development in the diabetes mouse [88].
Lipid rafts play a role in a number of signaling processes involving receptors that are expressed by a variety of cell types, including the EGFR receptor, integrin, and the insulin receptor. Ganglioside GM1 dramatically inhibits EGFR activation by changing the distribution of EGFR from the glycospingolipid-enriched microdomain (GEM) domain in human mammary epithelial cells [89]. These particular microdomains allow plasma membrane subcompartmentalization and the establishment of signaling platforms that intermediate physiological reactions. Mirkin et al. [90] noted that GM1 has a weak capacity to inhibit human neuroblastoma cell proliferation and EGFR phosphorylation. Moreover, treatment with GM1 significantly reduces phosphorylation of PDGFR by excluding the PDGFR from GEM domains [91]. For this reason, the overexpression of GM1 suppresses TrkA activiation by modulating the distribution of receptors from the lipid raft fraction to the non-raft fraction in PC12 cells [92]. Through this lens, it is seen that lipid rafts play an important role in cleavage furrow ingression and central spindle assembly. Toward this reasoning, GM1 is considered one of the important marker GSLs for lipid rafts, and it is easily detected with cholera toxin B subunit (CTX-B). Additionally, it is shown that GM1 detected with biotinylated CTX-B is enriched at the cleavage furrow in mouse 2-cell and 4-cell embryos that undergo cytokinesis [93]. GM1 accumulates in the perivitelline space in unfertilized mouse oocytes, and its accumulation increases after fertilization [94]. In consideration of this, GM1 microdomains are involved in the early stage of the fertilization procedures by supplying docking sites for spermatozoa in the human oolemma [40]. Bouvier et al. [95] demonstrated that predominant gangliosides were GD3 (52%), GM3 (19%), and GT1b in the E-12 mouse embryo, while b-series gangliosides, such as GD3, GD1b, GT1b, and GQ1b significantly reduced in the twl/twl mutant mouse. Ganglioside GM3 and GD3 are markedly expressed in mid-embryonic brains, but their expression is significantly decreased during later development when a- and b-series gangliosides are increased [96].
Calmodulin (CaM) is the major intracellular receptor for Ca2+ and regulates various intracellular enzymes that include protein phosphatases, ion channels, and protein kinases [97]. The CaMKII family of serine/threonine protein kinases regulates the transition of metaphase into anaphase in the cell cycle and has 28 isoforms originating from α, β, γ, and δ genes [98]. Here it is shown that CaMKII is involved in activation-like regulation of other proteins and meiotic resumption in porcine oocytes [99]. Moreover, in mouse oocytes, CaMKII also interacts with molecules that control cell cycle and Ca2+ signaling in mouse oocytes [100]. To be sure, CaMKII γ and CaMKII δ are expressed in porcine cumulus cells and oocytes [62]. Incidentally, it is noted that intracellular Ca2+ levels are increased with a higher concentration of GT1b in a dose-dependent manner during oocyte IVM [62]. The results show that the addition of GT1b to the culture medium temporarily activates CaMKII in neuroblastoma-glioma hybridoma (NG108-15) cells or rat hippocampal cells [101]. Several gangliosides, including GD1a play an important role in oocyte maturation via regulation of intracellular Ca2+ or EGF-induced EGFR phosphorylation. Exogenously added GD1a into culture medium promotes oocyte maturation and preimplantation development ability via stimulation of oocyte meiosis and maturation. On the other hand, exogenous GD1a decreases polyspermic fertilization in pigs [102]. Choo et al. [82] showed that GD1a is distributed within theca cells, interstitial cells, and oocytes during ovarian maturation in the rat. In addition, pre-treatment of GD1a increases EGFR dimerization, EGF-induced EGFR autophosphorylation, and receptor-tyrosine kinase activity in normal human dermal fibroblasts [103].

6. Conclusions

Gangliosides, which are sialic acid-containing glycosphingolipids, can be antioxidant candidates whose in vivo and in vitro applications have been demonstrated to efficiently protect sperm, oocytes, and embryos from ROS-produced injury. The preserving role of ganglioside GT1b against ROS-produced shifts is considered to originate from its ability to scavenge free radicals and protect from injury, whereas ganglioside GM3 induces apoptotic cell death in early embryos. To put it differently, exogenously added gangliosides improve oocyte maturity, monospermic fertilization, and preimplantation embryonic development.
Furthermore, recent work has placed gangliosides, with their various glycan structures spreading into the extracellular space and their lateral relations with signaling molecules in the cell membrane, among the significant controlling components involved in cell signaling and cell–cell recognition. Nevertheless, the important roles of gangliosides in the cell membrane require further investigation. Largely, it has been noted that ganglioside activity may contribute to the development of optimal cryoprotection techniques to preserve DNA integrity and culture conditions for assisted reproduction therapy.

Funding

This review was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) [No. 2019R1F1A107], [No. NRF-2017R1A4A1015594], the KRIBB Research Initiative Program (KGM4251824), and the Next Generation BioGreen 21 program [System and Synthetic Agrobiotech Center, PJ01342101], Republic of Korea. We would like to thank (www.editage.co.kr) for English language editing.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Edidin, M. The state of lipid rafts: From model membranes to cell. Ann. Rev. Biophys. Struct. 2003, 32, 257–283. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Brown, D. Lipid rafts, detergent-resistant membranes, and raft targeting signals. Physiology 2006, 21, 430–439. [Google Scholar] [CrossRef] [PubMed]
  3. Mclntosh, T.J. Overview of membrane rafts. Meth. Mol. Biol. 2007, 398, 1–9. [Google Scholar]
  4. Simons, K.; Ikonen, E. Functional rafts in cell membranes. Nature 1997, 387, 569–572. [Google Scholar] [CrossRef]
  5. Silvius, J.R. Partitioning of membrane molecules between raft and non-raft domains: Insights from membrane studies. Biochem. Biophys. Acta. 2005, 1746, 193–202. [Google Scholar] [CrossRef] [Green Version]
  6. Campbell, T.; Davy, A.; Liu, Y.; Arcellana-Panlilio, M.; Robbins, S. Distinct membrane compartmentalization and signaling of ephrin-A5 and ephrin-B1. Biochem. Biophys. Res. Commun. 2008, 375, 362–366. [Google Scholar] [CrossRef]
  7. Godoy, V.; Riquelme, G. Distinct lipid rafts in subdomains form human placental apical syncytiotrophoblast membranes. J. Membr. Biol. 2008, 224, 21–31. [Google Scholar] [CrossRef]
  8. Sonnino, S.; Mauri, L.; Chigorno, V.; Prinetti, A. Gangliosides as components of lipid membrane domains. Glycobiology 2007, 17, 1R–13R. [Google Scholar] [CrossRef] [Green Version]
  9. Kotani, M.; Kawashima, I.; Ozawa, H.; Terashima, T.; Tai, T. Differential distribution of major gangliosides in rat central nervous system detected by specific monoclonal antibodies. Glycobiology 1993, 3, 137–146. [Google Scholar] [CrossRef]
  10. Hakomori, S. Structure, organization and function of glycosphingolipids in membrane. Cur. Opin. Hematol. 2003, 10, 16–24. [Google Scholar] [CrossRef]
  11. Biswas, S.; Biswas, K.; Richmond, A.; Ko, J.; Chosh, S.; Simmons, M.; Rayman, P.; Rimi, B.; Gill, I.; Tannenbaum, C.S.; et al. Elevated levels of select gangliosides in T cells from renal cell carcinoma patients us associated with T cell dysfunction. J. Immunol. 2009, 183, 5050–5058. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Webb, T.J.; Li, X.; Giuntoli, R.L.; Lopez, P.H.; Heuser, C.; Schnaar, R.L.; Tsuji, M.; Kurts, C.; Oelke, M.; Schneck, J.P. Molecular identification of GD3 as a suppressor of the innate immune response in ovarian cancer. Cancer Res. 2012, 72, 3744–3752. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Sa, G.T.; Das, T.; Moon, C.; Hilston, C.M.; Rayman, P.A.; Rini, B.I.; Tannenbaum, C.S.; Finke, J.H. GD3, an overexpressed tumor-derived ganglioside, mediates the apoptosis of activated but not resting T cells. Cancer Res. 2009, 69, 3095–3104. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Dennery, P.A. Effects of oxidative stress on embryonic development. Birth defects Res. C. Embryo Today Rev. 2007, 81, 155–162. [Google Scholar] [CrossRef]
  15. Tripathi, A.; Khatun, S.; Pandey, A.N.; Mishra, S.K.; Chaube, R.; Shrivastav, T.G.; Chaube, S.K. Intracellular levels of hydrogen peroxide and nitric oxide in oocytes at various stages of meiotic cell cycle and apoptosis. Free Radic. Res. 2009, 43, 287–294. [Google Scholar] [CrossRef]
  16. Maulik, N.; Das, D.K.; Gogineni, M.; Cordis, G.A.; Avrova, N.; Denosova, N. Reduction of myocardial ischemic reperfusion injury by sialylated glycosphingolipids, gangliosides. J. Cardiovasc. Pharmacol. 1993, 22, 74–81. [Google Scholar] [CrossRef]
  17. Bondy, S.C.; Mckee, M.; Davoodbhoy, Y.M. Prevention of chemically induced changes in synaptosomal membrane order by ganglioside GM1 and α-tocooherol. Biochim. Biophys. Acta. 1990, 1026, 213–219. [Google Scholar] [CrossRef]
  18. Tyurin, V.A.; Tyurina, Y.Y.; Avrova, N.F. Ganglioside-dependent factor, inhibiting lipid peroxidation in rat brain synaptosomes. Neurochem. Int. 1992, 20, 401–407. [Google Scholar] [CrossRef]
  19. Tyurina, Y.Y.; Tyurin, V.A.; Avrova, N.F. Ganglioside GM1 protects cAMP 3`5`: Phosphodiesterase from inactivation caused by lipid peroxidation in brain synaptosomes of rats. Mol. Chem. Neuropathol. 1993, 19, 205–217. [Google Scholar] [CrossRef]
  20. Avrova, N.F.; Zakharova, I.O.; Tyurin, V.A.; Tyurina, Y.Y.; Gamaley, I.A.; Schepetkin, I.A. Different metabolic effects of ganglioside GM1 in brain synaptosome and phagocytic cells. Neurochem. Res. 2002, 27, 27,751–759. [Google Scholar] [CrossRef]
  21. Yamamoto, H.A.; Mohanan, P.V. Ganglioside GT1b and melatonin inhibit brain mitochondrial DNA damage and seizures induced by kainic acid and mice. Brain Res. 2003, 21, 100–106. [Google Scholar] [CrossRef]
  22. Gong, G.; Yin, L.; Yuan, L.; Sui, D.; Sun, Y.; Fu, H.; Chen, L.; Wang, X. Ganglioside GM1 protects against high altitude cerebral edema in rats by suppressing the oxidative stress and inflammatory response via the PI3K/AKT-Nrf2 pathway. Mol. Immunol. 2018, 95, 91–98. [Google Scholar] [CrossRef] [PubMed]
  23. Gavella, M.; Kveder, M.; Lipovac, V. Modulation of ROS production in human leukocytes by ganglioside micelles. Braz. J. Med. Biol. Res. 2010, 43, 942–949. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Kim, S.M.; Jung, J.U.; Ryu, J.S.; Jin, J.W.; Yang, H.J.; Ko, K.; You, H.K.; Jung, K.Y.; Choo, Y.K. Effects of gangliosides on the differentiation of human mesenchymal stem cells into osteoblasts by modulation epidermal growth factor receptors. Biochem. Biophys. Res. Commun. 2008, 371, 866–871. [Google Scholar] [CrossRef]
  25. Xu, Y.; Tan, L.J.; Grachtchouk, V.; Voorhees, J.J.; Fisher, G.J. Receptor-type protein-tysosine phosphatase-kappa regulated epidermal growth factors receptor function. J. Biol. Chem. 2005, 280, 42694–42700. [Google Scholar] [CrossRef] [Green Version]
  26. Ben-Yosef, D.; Galiani, D.; Dekel, N.; Shalgi, R. Rat oocytes induced to mature by epidermal growth factor are successfully fertilized. Mol. Cell Endocrionol. 1992, 88, 135–141. [Google Scholar] [CrossRef]
  27. De La Fuente, R.; O.’Brien, M.J.; Eppig, J.J. Epidermal growth factor enhances preimplantation developmental competence of maturing mouse oocytes. Hum. Reprod. 1999, 14, 3060–3068. [Google Scholar] [CrossRef] [Green Version]
  28. Illera, M.J.; Lorenzo, P.L.; Illera, J.C.; Petters, R.M. Developmental competence of immature pig oocytes under the influence of EGF, IGF-I, follicular fluid and gonadotropins during IVM-IVF processes. Int. J. Biol. 1998, 42, 1169–1172. [Google Scholar]
  29. Singh, B.; Meng, L.; Rutledge, J.M.; Armstrongs, D.T. Effects of epidermal growth factor and follicle-stimulating hormone during in vitro maturation on cytoplasmic maturation of porcine oocytes. Mol. Reprod. Dev. 1997, 46, 401–407. [Google Scholar] [CrossRef]
  30. Goud, P.T.; Goud, A.P.; Quan, C.; Laverge, H.; Van der Elst, J.; De Sutter, P.; Dhont, M. In-vitro maturation of human germinal vesicle stage oocytes role of cumulus cells and epidermal growth factor in the culture medium. Hum. Reprod. 1998, 13, 1638–1644. [Google Scholar] [CrossRef] [Green Version]
  31. Fujimoto, Y.; Izumoto, S.; Suzuki, T.; Kinoshita, M.; Kagawa, N.; Wada, K.; Hashimoto, N.; Maruno, M.; Nakatsuji, Y.; Yoshimine, T. Ganglioside GM3 inhibits proliferation and invasion of glioma. J. Neuroonco. 2005, 71, 99–106. [Google Scholar] [CrossRef] [PubMed]
  32. Chung, T.W.; Kim, S.J.; Choi, H.J.; Kim, K.J.; Kim, M.J.; Kim, S.H.; Lee, H.J.; Ko, J.H.; Lee, Y.C.; Suzuki, A.; et al. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: Direct interaction of GM3 with VEGFR-2. Glycobiology 2009, 19, 229–239. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Meuillet, E.J.; Mania-Farnell, B.; George, D.; Inokuchi, J.I.; Bremer, E.G. Modulation of EGF receptor activity by changes in the GM3 content in a human epidermoid carcinoma cell line, A431. Exp. Cell Res. 2000, 256, 74–82. [Google Scholar] [CrossRef] [PubMed]
  34. Watanabe, R.; Ohyama, C.; Aoki, H.; Takahashi, T.; Satoh, M.; Saito, S.; Hoshi, S.; Ishii, A.; Saito, M.; Arai, Y. Ganglioside GM3 overexpression induces apoptosis and reduces malignant potential in murine bladder cancer. Cancer Res. 2002, 62, 3850–3854. [Google Scholar]
  35. Huang, X.; Li, Y.; Zhang, J.; Xu, Y.; Tian, Y.; Ma, K. Ganglioside GM3 inhibits hepatoma cell motility via down-regulation activity of EGFR and PI3K/AKT signaling pathway. J. cell. Biocehm. 2013, 114, 1616–1624. [Google Scholar]
  36. Park, H.J.; Chae, S.K.; Kim, J.W.; Yang, S.G.; Jung, J.M.; Kim, M.J.; Wee, G.; Lee, D.S.; Kim, S.U.; Koo, D.B. Ganglioside GM3 induces cumulus apoptosis through inhibition of epidermal growth factors receptor-mediated PI3K/AKT signaling pathways during in vitro maturation of pig oocytes. Mol. Reprod. Dev. 2017, 84, 702–711. [Google Scholar] [CrossRef]
  37. Liu, Y.; Wond, A.; Bob, D.; Weiss, M.; Sliwinski, R.; Vilar, J.; Notario, V.; Sutherland, M.; Colberg-poley, A.M.; Ladisch, S. Ganglioside synthase knockout in oncogene-transformed fibroblasts depletes gangliosides and impairs tumor growth. Oncogen 2010, 29, 3297–3306. [Google Scholar] [CrossRef] [Green Version]
  38. Saito, M.; Ito, M.; Sugiyama, K. A specific loss of C-series gangliosides in pancreas of streptozotocin-induced diabetic rats. Life Sci. 1999, 64, 1803–1810. [Google Scholar] [CrossRef]
  39. Saito, M.; Sugiyama, K. A distinct ganglioside composition of rat pancreatic islets. Arch. Biochem. Biophys. 2000, 376, 371–376. [Google Scholar] [CrossRef]
  40. Van Blerkom, J.; Caltrider, K. Sperm attachment and penetration competence in the human oocyte: A possible aetiology of fertilization failure involving the organization of oolemmal lipid raft microdomains influenced by the ΔΨm of subplasmalemmal mitochondria. Reprod. Biomed. Online 2013, 27, 27,690–701. [Google Scholar] [CrossRef] [Green Version]
  41. Kolter, T.; Sandhoff, K. Recent advances in the biochemistry of sphingolipidoses. Brain Pathol. 1998, 79–100. [Google Scholar] [CrossRef] [PubMed]
  42. Jeckel, D.; Karrenbauer, A.; Burger, K.N.; van Meer, G.; Wieland, F. Glucosylceramide is synthesized at the cytosolic surface of various Golgi subfractions. J. cell. Biol. 1992, 117, 259–267. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Futerman, A.H.; Pagano, R.E. Determination of the intracellular sites and topology of glucosylceramide synthesis in rat liver. Biochem. J. 1991, 280, 295–302. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Marks, D.L.; Wu, K.; Paul, P.; Kamisaka, Y.; Watanabe, R.; Pagano, R.E. Oligomerization and topology of the Golgi membrane protein glucosylceramide synthase. J. Biol. Chem. 1999, 274, 451–456. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Yamashita, T.; Wada, R.A.; Sasaki, T.; Deng, C.; Bierfreund, U.; Sandhoff, K.; Proia, R.L. A vital role for glycosphingolipid synthesis during development and differentiation. Proc. Natl. Acad. Sci. USA 1999, 96, 9142–9147. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Kolesnick, R.N.; Kronke, M. Regulation of ceramide production and apoptosis. Annu. Rev. Physiol. 1998, 60, 643–665. [Google Scholar] [CrossRef]
  47. Hannun, Y.A.; Obeid, L.M. Ceramide and the eukaryotic stress response. Biochem. Soc. Trans. 1997, 25, 1171–1175. [Google Scholar] [CrossRef] [Green Version]
  48. Schauer, R. Sialic acids as link to Japanese scientists. Proc. Jpn. Acad. Ser. B. Phys. Biol. Sci. 2016, 92, 109–120. [Google Scholar] [CrossRef] [Green Version]
  49. Tanner, M.E. The enzymes of sialic acid biosynthesis. Bioorg. Chem. 2005, 33, 216–228. [Google Scholar] [CrossRef]
  50. YU, R.K.; Tsai, Y.; Ariga, T.; Yanagisawa, M. Structures, biosynthesis, and functions of gangliosides- an overview. J.Oleo.Sci. 2011, 60, 537–544. [Google Scholar] [CrossRef] [Green Version]
  51. Kuhn, R.; Wiegandt, H. Die Konstitution der Ganglio-N-Tetraose und des gangliosids G1. Chember. 1963, 96, 866. [Google Scholar]
  52. Mahadik, S.P.; Karpiak, S.K. Gangliosides in treatment of neural injury and disease. Drug Dev. Res. 1998, 15, 337–360. [Google Scholar] [CrossRef]
  53. Inokuchi, J. Membrane microdomains and insulin resistance. FEBS. Lett. 2010, 584, 1864–1871. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Regina Todeschini, A.; Hakomori, S.I. Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains. Biochim. Biophys. Acta. 2008, 1780, 421–433. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  55. Ohmi, Y.; Ohkawa, Y.; Yamauchi, Y.; Tajima, O.; Furukawa, K.; Furukawa, K. Essential roles of gangliosides in the formation and maintenance of membrane microdomains in brain tissues. Neurochem. Res. 2012, 37, 1185–1191. [Google Scholar] [CrossRef] [PubMed]
  56. Furukawa, K.; Hamamura, K.; Ohkawa, Y.; Ohmi, Y.; Furukawa, K. Disialyl gangliosides enhance tumor phenotypes with differential modalities. Glycoconj. J. 2012, 29, 579–584. [Google Scholar] [CrossRef]
  57. Hakomori, S.I.; Handa, K. GM3 and cancer. Glycoconj. J. 2015, 32, 1–8. [Google Scholar] [CrossRef]
  58. Ledeen, R.W.; Wu, G.; Andre, S.; Bleich, D.; Huet, D.; Kaltner, H.; Koptiz, J.; Gablus, H.J. Beyond glycoproteins as galectin counterreceptors:tumor-effector T cell growth control via ganglioside GM1 [corrected]. Ann. N. Y. Acad. Sci. 2012, 1253, 206–221. [Google Scholar] [CrossRef]
  59. Lipina, C.; Hundal, H.S. Ganglioside GM3 as a gatekeeper of obesity-associated insulin resistance: Evidence and mechanisms. Febs. Lett. 2015, 589, 3221–3227. [Google Scholar] [CrossRef] [Green Version]
  60. Allende, M.L.; Proia, R.L. Simplifying complexity: Genetically resculpting glycosphingolipid synthesis pathways in mice to reveal function. Glycoconj. J. 2014, 31, 613–622. [Google Scholar] [CrossRef] [Green Version]
  61. Avrova, N.F.; Victorov, I.V.; Tyurin, V.A.; Zakharova, I.O.; Sokolova, T.V.; Andreeva, N.A.; Stelmaschuk, E.V.; Tyurina, Y.Y.; Gonchar, V.S. Inhibition of glutamate-induced intensification of free radical reactions by ganglioside: Possible role in their protective effect in rat cerebella granule cells and phagocytic cell. Neurochem. Res. 1998, 23, 945–952. [Google Scholar] [CrossRef] [PubMed]
  62. Hwang, S.U.; Jeon, Y.; Youn, J.D.; Cai, L.; Kim, E.; Yoo, H.; Kim, K.J.; Park, K.M.; Jin, M.; Kim, H.; et al. Effect of ganglioside GT1b on the in vitro maturation of porcine oocytes and embryonic development. J. Reprod. Dec. 2015, 61, 549–557. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  63. Tamburino, L.; Marchiani, S.; Montoya, M.; Elia Marino, F.; Natail, I.; Cambi, M.; Forti, D.; Baldi, E.; Muratori, M. Mechanisms and clinical correlates of sperm DNA damage. Asianj. Androl. 2012, 14, 24–31. [Google Scholar] [CrossRef] [PubMed]
  64. Thomson, L.K.; Fleming, S.D.; Aitken, R.J.; De, G.N.; Zieschang, J.A.; Clark, A.M. Cryopreservation-induced human sperm DNA damage is predominantly mediated by oxidative stress rather than apoptosis. Hum. Reprod. 2009, 24, 2061–2070. [Google Scholar] [CrossRef] [Green Version]
  65. Zribi, N.; Chakroun, N.K.; El Euch, H.; Gargouri, J.; Bahloul, A.; Ammar Keskes, L. Effects of cryopreservation on human sperm deoxyribonucleic acid integrity. Fertil. Steril. 2010, 93, 159–166. [Google Scholar] [CrossRef]
  66. Kim, B.H.; Jung, J.U.; Ko, K.; Kim, W.S.; Ryu, J.S.; Jun, J.W.; Yang, H.J.; Kim, J.S.; Kwon, H.C.; Nam, S.Y.; et al. Expression of ganglioside GT1b in mouse embryos at different development stages after cryopreservation. Arch. Pham. Res. 2008, 31, 88–95. [Google Scholar] [CrossRef]
  67. James, P.S.; Wolfe, C.A.; Mackie, A.; Ladha, S.; Prentice, A.; Jones, R. Lipid dynamics in the plasma membrane of fresh and cryopreserved human spermatozoa. Hum. Reprod. 1999, 14, 1827–1832. [Google Scholar] [CrossRef] [Green Version]
  68. Chakrabarty, J.; Banerjee, D.; Pal, J.; De, J.; Ghosh, A.; Majumder, G.C. Shedding off specific lipid constituents from sperm cell membrane during cryopreservation. Cryobiology 2007, 54, 27–35. [Google Scholar] [CrossRef]
  69. Sautter, J.; Hoglinger, G.U.; Oertel, W.H.; Earl, C.D. Systemic treatment with GM1 ganglioside improves survival and function of cryopreserved embryonic midbrain grafted to the 6-hydroxydopamind-lesioned rat striatum. Exp. Neurol. 2000, 164, 121–129. [Google Scholar] [CrossRef]
  70. Gavella, M.; Lipova, V.; Rakos, R.; Colak, B. Reduction of oxidative changes in human spermatozoa by exogenous gangliosides. Andrologia 2005, 37, 17–24. [Google Scholar] [CrossRef]
  71. Jung, K.Y.; Kim, B.H.; Hwang, M.R.; Cho, J.R.; Kim, H.M.; Lee, Y.C.; Kim, C.H.; Kim, J.K.; Kim, B.J.; Choo, Y.K. Differential distribution of gnaglioside GM3 in seminiferous tubule and epididymis of adult rats. Arch. Pham. Res. 2001, 4, 360–366. [Google Scholar] [CrossRef] [PubMed]
  72. Takamiya, K.; Yamamoto, A.; Furukawa, K.; Yamashiro, S.; Shin, M.; Okada, M.; Fukumoto, S.; Haraguchi, M.; Takeda, N.; Fujimura, K.; et al. Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. Proc. Natl. Acad. Sci. USA 1996, 93, 10662–10667. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  73. Takamiya, K.; Yamamoto, A.; Furukawa, K.; Zhao, J.; Fukumoto, S.; Yamashiro, S.; Okada, M.; Haraguchi, M.; Shin, M.; Kishikawa, M.; et al. Complex gangliosides are essential in spermatogenesis of mice: Possible roles in the transport of testosterone. Proc. Natl. Acad. Sci. USA 1998, 1998. 95, 12147–12152. [Google Scholar] [CrossRef] [Green Version]
  74. Aitken, R.J.; Gordon, E.; Harkiss, D.; Twigg, J.P.; Milne, P.; Jennings, Z.; Irvine, D.S. Relative impact of oxidative stress on the functional competence and genomic integrity of human spermatozoa. Biol. Reprod. 1998, 59, 1037–1046. [Google Scholar] [CrossRef] [PubMed]
  75. Baldi, E.; Luconi, M.; Bonaccorsi, L.; Muratori, M.; Forti, G. Intracellular events and signaling pathways involved in sperm acquisition of fertilizing capacity and acrosome reaction. Front. Biosci. 2000, 5, E110–E123. [Google Scholar] [CrossRef] [Green Version]
  76. Visconti, P.E.; Bailey, J.L.; Moore, G.D.; Pan, D.; Olds-Clarke, P.; Kopf, G.S. Capacitation of mouse spermatozoa. I. Correction between the capacitation state and protein tyrosine Phosphorylation. Development 1995, 121, 1129–1137. [Google Scholar] [PubMed]
  77. Shadan, S.; James, P.S.; Howes, E.A.; Jones, R. Cholesterol efflux alters lipid raft stability and distribution during capacitation of boar spermatozoa. Biol. Reprod. 2004, 71, 253–265. [Google Scholar] [CrossRef] [Green Version]
  78. Roberts, K.P.; Wamstad, J.A.; Ensrud, K.M.; Hamilton, D.W. Inhibition of capacitation-associated tyrosine phosphorylation signaling in rat sperm by epididymal protein Crisp-1. Biol. Reprod. 2003, 69, 572–581. [Google Scholar] [CrossRef] [Green Version]
  79. Dunning, K.R.; Watson, L.N.; Zhang, V.J.; Brown, H.M.; Kaczmarek, A.K.; Robker, R.L.; Russell, D.L. Activation of Mouse Cumulus-Oocyte Complex Maturation In Vitro Through EGF-Like Activity of Versican. Biol. Reprod. 2015, 92, 116. [Google Scholar] [CrossRef] [Green Version]
  80. Selvaraj, V.; Buttke, D.E.; Asano, A.; McElwee, J.L.; Wolff, C.A.; Nelson, J.L.; Klaus, A.V.; Hunnicutt, G.R.; Travis, A.J. GM1 dynamics as a marker for membrane changes associated with the process of capacitation in murine and bovine spermatozoa. J. Androl. 2007, 28, 588–599. [Google Scholar] [CrossRef]
  81. Moody, M.A.; Cardona, C.; Simpson, A.J.; Smith, T.T.; Travis, A.J.; Ostermeier, G.C. Validation of a laboratory-developed test of human sperm capacitation. Mol. Reprod. Dev. 2017, 84, 408–422. [Google Scholar] [CrossRef] [PubMed]
  82. Choo, Y.K.; Chiba, T.C.; Tai, T.; Ogiso, M.; Hoshi, M. Differential distribution of gangliosides in adult rat ovary during the oestrous cycle. Glycobiology 1995, 5, 299–309. [Google Scholar] [CrossRef] [PubMed]
  83. Choo, Y.K. Distribution of ganglioside GM3 in the rat ovary after gonadotropin stimulation. Mol. Cells 1999, 9, 365–375. [Google Scholar] [PubMed]
  84. Rebbaa, A.; Hurh, J.; Yamamoto, H.; Kersey, D.S.; Bremer, E.G. Ganglioside GM3 inhibition of EGF receptor mediated signal transduction. Glycobiology 1996, 6, 399–406. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  85. Chung, T.W.; Choi, H.J.; Kim, S.J.; Kwak, C.H.; Song, K.H.; Jun, U.H.; Chang, Y.C.; Chang, H.W.; Lee, Y.C.; Ha, K.T.; et al. The ganglioside GM3 in associated with cisplatin-induced apoptosis in human colon cancer cells. PLoS. ONE. 2014, 9, e92786. [Google Scholar] [CrossRef] [PubMed]
  86. Yamashita, T.; Hashiramoto, A.; Haluzik, M.; Mizukami, H.; Beck, S.; Norton, A.; Kono, M.; Tsuji, S.; Daniotti, J.L.; Werth, N.; et al. Enhanced insulin sensitivity in mice lacking ganglioside GM3.Proc. Natl. Acad. Sci. USA 2003, 100, 3445–3459. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  87. Ju, E.J.; Kwak, D.H.; Lee, D.H.; Kim, S.M.; Kim, J.S.; Choi, H.G.; Jung, K.Y.; Lee, S.U.; Do, S.I.; Park, Y.I.; et al. Pathophysiological implication of ganglioside GM3 in early mouse embryonic development through apoptosis. Arch. Pham. Res. 2005, 28, 1057–1064. [Google Scholar] [CrossRef]
  88. Kwak, D.H.; Jung, K.Y.; Lee, Y.C.; Choo, Y.K. Expressional changes of ganglioside GM3 during ovarian maturation and early embryonic development in db/db mice. Dev. Growth. Differ. 2003, 45, 95–102. [Google Scholar] [CrossRef] [Green Version]
  89. Zhuo, D.; Guan, F. Ganglioside GM1 promotes contact inhibition of growth by regulating the localization of epidermal growth factor receptor from glycospingolipid-enriched microdomain to caveolae. Cell Prolif. 2019, 52, e12639. [Google Scholar] [CrossRef]
  90. Mirkin, B.L.; Clark, S.H.; Zhang, C. Inhibition of human neuroblastoma cell proliferation and EGF receptor phosphorylation by gangliosides GM1, GM3, GD1A and GT1B. Cell Prolif. 2002, 35, 105–115. [Google Scholar] [CrossRef]
  91. Mitsuda, T.; Furukawa, K.; Fukumoto, S.; Miyazaki, H.; Urano, T.; Furukawa, K. Overexpression of ganglioside GM1 results in the dispersion of platelet-derived growth factor receptor from glycolipid-enriched microdomains and in the suppression of cell growth signals. J. Biol. Chem. 2002, 277, 11239–11246. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  92. Nishio, M.; Fukumoto, S.; Furukawa, K.; Ichimura, A.; Miyazaki, H.; Kusunokis, S.; Urano, T.; Furukawa, K. Overexpressed GM1 suppresses nerve growth factor (NGF) signals by modulating the intracellular localization of NGF receptors and membrane fluidity in PC12 cells. J. Biol. Chem. 2004, 279, 33368–33378. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  93. Comiskey, M.; Warner, C.M. Spatio-temporal localization of membrane lipid rafts in mouse oocytes and cleaving preimplantation embryos. Dev Biol. 2007, 303, 727–739. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  94. Sato, B.; Katagiri, Y.U.; Miyado, K.; Okino, N.; Ito, M.; Akutsu, H.; Okita, H.; Umezawa, A.; Fujimoto, J.; Toshimori, K.; et al. Lipid rafts enriched in monosialylGb5Cer carrying the stage-specific embryonic antigen-4 epitope are involved in development of mouse preimplantation embryos at cleavage stage. BMC. Dev. Biol. 2011, 11, 22. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  95. Bouvier, J.D.; Seyfired, T.N. Ganglioside composition of normal mutant mouse embryos. J. Neurochem. 1989, 52, 460–466. [Google Scholar] [CrossRef] [PubMed]
  96. Ngamukote, S.; Yanagisawa, M.; Ariga, T.; Ando, S.; Yu, R.K. Developmental changes of glycoshingolipids and expression of glycogens in mouse brains. J. Neurochem. 2007, 103, 2327–2341. [Google Scholar] [CrossRef]
  97. Kahl, C.R.; Means, A.R. Regulation of cell cycle progression by calcium/calmodulin dependent pathways. Endroc. Rev. 2003, 24, 719–736. [Google Scholar] [CrossRef] [Green Version]
  98. Hudmon, A.; Schulman, H. Neuronal CA2+/calmodulin-dependent protein kinase II: The role of structure and autoregulation in cellular function. Biochem. J. 2002, 364, 593–611. [Google Scholar] [CrossRef]
  99. Fan, H.Y.; Sun, Q.Y. Involvement of mitogen-activated protein kinase cascade during oocyte maturation and fertilization in mammals. Biol. Reprod. 2003, 69, 1552–1564. [Google Scholar] [CrossRef] [Green Version]
  100. Su, Y.Q.; Eppig, J.J. Evidence that multifunctional calcium/calmodulin-dependent protein kinase II (CaM KII) participates in the meiotic maturation of mouse oocytes. Mol. Reprod. Dev. 2002, 61, 560–569. [Google Scholar] [CrossRef]
  101. Chen, N.; Furuya, S.; Dol, H.; Hashimoto, Y.; Kudo, Y.; Higashi, H. Ganglioside/calmodulin kinaseII signal inducing cdc-42 mediated neuronal actin reorganization. Neuroscience 2003, 120, 163–176. [Google Scholar] [CrossRef]
  102. Kim, J.W.; Park, H.J.; Chae, S.k.; Ahn, J.H.; Do, G.Y.; Choo, Y.K.; Park, J.J.; Jung, B.D.; Kim, S.U.; Chang, K.T.; et al. Ganglioside GD1a promotes oocyte maturation, furthers preimplantation development, and increases blastocyst quality in pigs. J. Reprod. Dev. 2016, 62, 249–255. [Google Scholar] [CrossRef] [PubMed]
  103. Liu, Y.; Li, R.; Ladisch, S. Exogenous ganglioside GD1a enhances epidermal growth factor receptor binding and dimerization. J. Biol. Chem. 2004, 279, 36481–36489. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  104. Miljan, E.A.; Meuillet, E.J.; Mania-Farnell, B.; George, D.; Yamamoto, H.; Simon, H.; Bremer, E.G. Interaction of the extracellular domain of the epidermal growth factor receptor with ganglioside. J. Biol. Chem. 2002, 277, 10108–10113. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  105. Bremer, E.G.; Schlessinger, J.; Hakomori, S. Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor. J.Biol.Chem. 1986, 261, 2434–2440. [Google Scholar]
  106. Vivanco, I.; Sawyers, C.L. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer 2002, 2, 489–501. [Google Scholar] [CrossRef]
  107. Byeon, H.G.; Ku, M.; Yang, J. Beyond EGFR inhibition: Multilateral combat strategies to stop the progression of head and neck cancer. Exp. Mol. Med. 2019, 51, 8. [Google Scholar] [CrossRef] [Green Version]
  108. Tsai, S.C.; Lu, C.C.; Lee, C.Y.; Lin, Y.C.; Chung, J.G.; Kuo, S.C.; Amagaya, S.; Chen, F.N.; Chen, M.Y.; Chan, S.F. AKT serine/threonine protein kinase modulates bulfalin-triggered intrinsic pathway of apoptosis in CAL 27 oral cancer cells. Int. J. Oncol. 2012, 41, 1683–1692. [Google Scholar] [CrossRef] [Green Version]
  109. Xiong, S.; Mu, T.; Wang, G.; Jiang, X. Mitochondria-mediated apoptosis in mammals. Protein Cell 2014, 5, 737–749. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Ganglioside structure. (A) Structure of GM3 monoganglioside. (B) Structure of trisialoganglioside GT1b. (C) Structure of GD1a. (D) Structure of GM1a.
Figure 1. Ganglioside structure. (A) Structure of GM3 monoganglioside. (B) Structure of trisialoganglioside GT1b. (C) Structure of GD1a. (D) Structure of GM1a.
Ijms 21 00106 g001
Figure 2. Protective effects of exogenous ganglioside micelles from ROS-induced damage in the ejaculated spermatozoa. Exogenous gangliosides are absorbed to the sperm surface and reduce the superoxide anion level generated by PMA-stimulated spermatozoa. O-2 is converted into H2O2 by cytosolic-localized SOD1 (Cu, Zn, SOD), mitochondria-localized SOD2 (Mn SOD), and the extracellular SOD3 (Fe SOD). Ganglioside GT1b reduces Fe2+-mediated decomposition of lipid hydroperoxydes from the sperm membrane. Consequently, GT1b prevents lipid peroxidation induced sperm membrane damage due to its specific molecular structure, such as micelles [16,20,70].
Figure 2. Protective effects of exogenous ganglioside micelles from ROS-induced damage in the ejaculated spermatozoa. Exogenous gangliosides are absorbed to the sperm surface and reduce the superoxide anion level generated by PMA-stimulated spermatozoa. O-2 is converted into H2O2 by cytosolic-localized SOD1 (Cu, Zn, SOD), mitochondria-localized SOD2 (Mn SOD), and the extracellular SOD3 (Fe SOD). Ganglioside GT1b reduces Fe2+-mediated decomposition of lipid hydroperoxydes from the sperm membrane. Consequently, GT1b prevents lipid peroxidation induced sperm membrane damage due to its specific molecular structure, such as micelles [16,20,70].
Ijms 21 00106 g002
Figure 3. Exogenous GM3 and the EGFR-mediated PI3K/AKT signal pathway. Exogenously added GM3 binds to the extracellular domain of EGFR and inhibits its dimerization [104] without inhibiting ligand binding [105]. Exogenous GM3 inhibits EGF-induced phosphorylation of EGFR at the Tyr-1173 residue [35]. After inhibition by blocking phosphorylation, the inhibited signal from the EGFR prevents one of the three downstream signaling pathways, PI3K, AKT, or mTOR. PI3K and AKT activation is reduced [106]. Upon inhibition of the phosphorylation of PI3K, AKT subsequently suppresses the phosphorylation of mTOR, which mediates protein synthesis [107]. This mechanism for suppressed EGFR activity might reduce cell proliferation and inhibit the repair of DNA damage [108]. The activation changes of these pro- and anti-apoptotic proteins is initiated in mitochondria [109]. Continuous mitochondrial regulation releases pro-apoptotic proteins such as cytochrome c into the cytoplasm causing caspase cascades processed by apoptosis, the programed cell death [52].The most compelling evidence shows that GM3 treatment decreases phosphorylated EGFR levels and regulates down-stream EGFR activation in cumulus-oocyte complexes COCs. Consequently, GM3 exposure reduces EGFR-delivered PI3K/AKT signaling for proliferation during in vitro maturation of porcine COCs [36].
Figure 3. Exogenous GM3 and the EGFR-mediated PI3K/AKT signal pathway. Exogenously added GM3 binds to the extracellular domain of EGFR and inhibits its dimerization [104] without inhibiting ligand binding [105]. Exogenous GM3 inhibits EGF-induced phosphorylation of EGFR at the Tyr-1173 residue [35]. After inhibition by blocking phosphorylation, the inhibited signal from the EGFR prevents one of the three downstream signaling pathways, PI3K, AKT, or mTOR. PI3K and AKT activation is reduced [106]. Upon inhibition of the phosphorylation of PI3K, AKT subsequently suppresses the phosphorylation of mTOR, which mediates protein synthesis [107]. This mechanism for suppressed EGFR activity might reduce cell proliferation and inhibit the repair of DNA damage [108]. The activation changes of these pro- and anti-apoptotic proteins is initiated in mitochondria [109]. Continuous mitochondrial regulation releases pro-apoptotic proteins such as cytochrome c into the cytoplasm causing caspase cascades processed by apoptosis, the programed cell death [52].The most compelling evidence shows that GM3 treatment decreases phosphorylated EGFR levels and regulates down-stream EGFR activation in cumulus-oocyte complexes COCs. Consequently, GM3 exposure reduces EGFR-delivered PI3K/AKT signaling for proliferation during in vitro maturation of porcine COCs [36].
Ijms 21 00106 g003

Share and Cite

MDPI and ACS Style

Kim, B.H.; Ju, W.S.; Kim, J.-S.; Kim, S.-U.; Park, S.J.; Ward, S.M.; Lyu, J.H.; Choo, Y.-K. Effects of Gangliosides on Spermatozoa, Oocytes, and Preimplantation Embryos. Int. J. Mol. Sci. 2020, 21, 106. https://doi.org/10.3390/ijms21010106

AMA Style

Kim BH, Ju WS, Kim J-S, Kim S-U, Park SJ, Ward SM, Lyu JH, Choo Y-K. Effects of Gangliosides on Spermatozoa, Oocytes, and Preimplantation Embryos. International Journal of Molecular Sciences. 2020; 21(1):106. https://doi.org/10.3390/ijms21010106

Chicago/Turabian Style

Kim, Bo Hyun, Won Seok Ju, Ji-Su Kim, Sun-Uk Kim, Soon Ju Park, Sean M. Ward, Ju Hyeong Lyu, and Young-Kug Choo. 2020. "Effects of Gangliosides on Spermatozoa, Oocytes, and Preimplantation Embryos" International Journal of Molecular Sciences 21, no. 1: 106. https://doi.org/10.3390/ijms21010106

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop